FY2023 Trading Update - welcome regulatory and R&D progress
RUA Life Sciences trading update included Group revenues and year-end cash position were modestly...
Read moreSustainable growth & offering 65% potential upside
Vp, the specialist equipment rental business, today released ‘in line’ final FY’23 results & a...
Read moreMarket trends support outlook for year ahead
This new report adds our FY24e forecasts which incorporate (a) full contributions from recent...
Read more
A clear route to realise project value
Minoan has progressively eliminated most of the outstanding issues which have delayed delivery of...
Read moreFull Year 2022 Results
Kinarus has published its Annual Report for 2022. The challenging funding environment has delayed...
Read morePoised to thrive in ‘sustainable investing 2.0’
Impax’s recent AUM progress during another period of market turmoil looks more impressive than we...
Read moreAGM update and CEO transition
Destiny’s AGM provided a summary of an eventful year that included the licensing of its lead Phase...
Read moreIn position for sustainable growth
The recent Operating Review of trading up to the end of FY22 was positive, with good growth in...
Read moreFunding the opportunity in medical imaging
On 18 April Kromek announced a major seven-year agreement with a Tier 1 OEM to develop and...
Read moreFY 23 trading update: ahead and unified
In a Trading Update for the year to 30 April 2023, Cohort plc expects performance to be slightly...
Read moreH1 23 results: a robust base for expansion
For the six months to 31/3/2023, Benchmark Holdings reported revenue of £98.9m, +24.8%YoY...
Read moreRegister to be first
Get research on the companies that interest you straight to your inbox
